Nanocomplexes for gene therapy of respiratory diseases: Targeting and overcoming the mucus barrier
- 1 October 2015
- journal article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 34, 8-24
Abstract
No abstract availableKeywords
Funding Information
- MIUR (Ministero dell'Istruzione, dell'Università e della Ricerca)
- Progetto PRIN (2010H834LS_005, 20109PLMH2)
This publication has 162 references indexed in Scilit:
- Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung CancerMolecular Therapy Nucleic Acids, 2013
- PEGylated Polyplex With Optimized PEG Shielding Enhances Gene Introduction in Lungs by Minimizing Inflammatory ResponsesMolecular Therapy, 2012
- N-acetylcysteine Enhances Cystic Fibrosis Sputum Penetration and Airway Gene Transfer by Highly Compacted DNA NanoparticlesMolecular Therapy, 2011
- Vascular endothelial platelet endothelial cell adhesion molecule 1 (PECAM-1) regulates advanced metastatic progressionProceedings of the National Academy of Sciences, 2010
- Targeting of the prostacyclin specific IP1 receptor in lungs with molecular conjugates comprising prostaglandin I2 analoguesBiomaterials, 2010
- Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrierProceedings of the National Academy of Sciences, 2009
- The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticlesBiomaterials, 2009
- Micro- and macrorheology of mucusAdvanced Drug Delivery Reviews, 2009
- Addressing the PEG Mucoadhesivity Paradox to Engineer Nanoparticles that “Slip” through the Human Mucus BarrierAngewandte Chemie International Edition, 2008
- Rapid transport of large polymeric nanoparticles in fresh undiluted human mucusProceedings of the National Academy of Sciences, 2007